David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GMS
1701
DELISTED
GMS Inc
GMS
| $3.76M | ﹤0.01% |
248,549
-36,893
| -13% | -$667K |
|
1702
Archrock
AROC
$5.55B
| $3.76M | ﹤0.01% |
384,015
-287,186
| -43% | -$2.75M |
|
1703
Essential Utilities
WTRG
$11.6B
| $3.76M | ﹤0.01% |
103,077
-11,733
| -10% | -$414K |
|
|
BCOV
1704
DELISTED
Brightcove, Inc.
BCOV
| $3.75M | ﹤0.01% |
446,177
-8,171
| -2% | -$65.8K |
|
|
INOV
1705
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $3.75M | ﹤0.01% |
301,932
+80,785
| +37% | +$1.09M |
|
|
INWK
1706
DELISTED
InnerWorkings, Inc.
INWK
| $3.75M | ﹤0.01% |
1,034,568
+232,148
| +29% | +$1.04M |
|
1707
Huron Consulting
HURN
$2.49B
| $3.74M | ﹤0.01% |
79,273
+5,295
| +7% | +$261K |
|
1708
Apple Hospitality REIT
APLE
$3.91B
| $3.74M | ﹤0.01% |
229,479
-699,896
| -75% | -$11.2M |
|
1709
Walker & Dunlop
WD
$1.38B
| $3.74M | ﹤0.01% |
73,445
-111,338
| -60% | -$5.65M |
|
1710
Cable One
CABO
$147M
| $3.74M | ﹤0.01% |
3,808
-121
| -3% | -$110K |
|
1711
Rio Tinto
RIO
$170B
| $3.73M | ﹤0.01% |
63,444
-508,104
| -89% | -$27.9M |
|
1712
Landstar System
LSTR
$6.16B
| $3.72M | ﹤0.01% |
34,005
-90,613
| -73% | -$9.55M |
|
1713
PUT
ServiceNow
NOW
$130B
| $3.7M | ﹤0.01% |
75,000
-263,500
| -78% | -$11.6M |
|
1714
CALL
Madison Square Garden
MSGS
$9.59B
| $3.69M | ﹤0.01% |
17,665
-30,003
| -63% | -$6.1M |
|
1715
CALL
Vertex Pharmaceuticals
VRTX
$139B
| $3.68M | ﹤0.01% |
20,000
| – | – |
|
|
ACBI
1716
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $3.67M | ﹤0.01% |
205,938
+53,620
| +35% | +$990K |
|
|
GWR
1717
DELISTED
Genesee & Wyoming Inc.
GWR
| $3.67M | ﹤0.01% |
42,080
+32,478
| +338% | +$2.63M |
|
1718
American Homes 4 Rent
AMH
$12.3B
| $3.66M | ﹤0.01% |
160,935
-254,550
| -61% | -$5.58M |
|
1719
OR Royalties Inc
OR
$7.2B
| $3.63M | ﹤0.01% |
322,949
+311,115
| +2,629% | +$3.2M |
|
1720
POSCO
PKX
$17.7B
| $3.62M | ﹤0.01% |
65,641
-62,702
| -49% | -$3.63M |
|
1721
Nomura Holdings
NMR
$29.4B
| $3.62M | ﹤0.01% |
1,007,656
-78,290
| -7% | -$306K |
|
1722
Independent Bank Corp
IBCP
$815M
| $3.61M | ﹤0.01% |
168,100
-21,172
| -11% | -$476K |
|
1723
Magnachip Semiconductor
MX
$119M
| $3.61M | ﹤0.01% |
487,920
+149,349
| +44% | +$1.06M |
|
1724
Terex
TEX
$7.47B
| $3.61M | ﹤0.01% |
112,395
+102,456
| +1,031% | +$3.25M |
|
|
NCI
1725
DELISTED
Navigant Consulting, Inc.
NCI
| $3.61M | ﹤0.01% |
185,410
-269,987
| -59% | -$6.31M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.